Compare Kymera Therapeutics Inc. Common Stock (KYMR) vs Powell Industries (POWL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kymera Therapeutics Inc. Common Stock vs Powell Industries — how do they compare? Kymera Therapeutics Inc. Common Stock trades at $106.81 (market cap $8.88B), while Powell Industries trades at $165.18 (market cap $6.18B). The key difference: Kymera Therapeutics Inc. Common Stock is the larger of the two by market cap, and Powell Industries pays a 0.21% dividend while Kymera Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Kymera Therapeutics Inc. Common Stock for 0 Days and Powell Industries for 6 Days on average.
| KYMR | POWL | |
|---|---|---|
Market Cap | $8.88B | $6.18B |
Volume | 1,028,790 | 1,083,698 |
Sector | Health | Industrials |
52-Week High | $127.31 | $322.05 |
52-Week Low | $55.80 | $94.02 |
Typical Hold Time | 0 Days | 6 Days |
Enterprise Value | $8.27B | $5.55B |
Dividend Yield | — | 0.21% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Powell Industries (POWL) trades at $182.79, down 1.4% with bearish technical signals. The company shows strong profitability with 16.49% net margin and 28.25% ROE, though recent quarters missed earnings estimates. Analyst consensus is mixed with 30% buy ratings but a $284 price target suggesting 55% upside. The stock faces near-term pressure from technical weakness despite solid fundamentals and a $2.4 billion backlog supporting future growth.
The investment case balances strong operational performance against technical headwinds. Upside potential exists from backlog conversion and capacity expansion, but risks include execution challenges and market volatility. With valuation metrics elevated (P/E 34.99), successful earnings delivery in upcoming quarters remains critical for sustaining investor confidence and achieving analyst targets.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Kymera Therapeutics Inc. Common Stock
Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.
Read more on KYMR →About Powell Industries
Powell Industries designs and manufactures electrical equipment and engineered solutions for power distribution and control. Its products are used across energy, utility, industrial, and commercial infrastructure.
Read more on POWL →
